Arkolith/Insider Trading/AXSM/Form 4

Jeffs Roger

DirectorAxsome Therapeutics, Inc. (AXSM) · full profile →Form 4 · filed Jun 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$142K
Net Open-Market Flow
-$142K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 11, 2026Sell(S)286$249.12$71K58K
Jun 10, 2026Sell(S)286$246.18$70K59K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-268202) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML